Cullinan Therapeutics
CGEM
#6883
Rank
$0.45 B
Marketcap
$7.76
Share price
-4.73%
Change (1 day)
-71.40%
Change (1 year)

P/S ratio for Cullinan Therapeutics (CGEM)

P/S ratio as of April 2025 (TTM): N/A

According to Cullinan Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.7753. At the end of 2024 the company had a P/S ratio of N/A.

P/S ratio history for Cullinan Therapeutics from 2021 to 2024

PS ratio at the end of each year

Year P/S ratio Change
2024N/A
2023N/A
2022N/A-100%
202135.6